TRAP Methodology for Cell-Type-Specific Gene Expression Profiling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for characterizing gene expression in complex tissues, such as the nervous system, face challenges due to cellular heterogeneity, stress during isolation procedures, and technical difficulties in reproducible mRNA purification from fixed tissue, limiting the identification of gene transcripts in individual cell types.
Innovation Solution
The development of a translating ribosome affinity purification (TRAP) methodology, which involves isolating ribosome complexes from cells with a tagged ribosomal protein expressed under specific regulatory sequences, allowing for the purification of translated mRNAs from defined cell types without the need for cell isolation, enabling the identification of translational profiles and co-regulated gene sets.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If cell isolation procedures are used to characterize gene expression in complex tissues, then gene expression can be analyzed at the cellular level, but stress during isolation procedures and loss of tissue-intrinsic signals occur
Solution Approach 1:
The patent extracts and purifies ribosome complexes directly from tissue sections without isolating individual cells. By using affinity purification to isolate ribosomes bound to specific mRNA sequences, the method obtains cell-type-specific translational profiles while avoiding the harmful isolation procedures that stress cells and alter their gene expression patterns.
Solution Approach 2:
The patent uses ribosome complexes as an intermediary to access cell-type-specific gene expression information. Instead of directly isolating and analyzing cells, the method purifies ribosomes that are naturally present in tissue sections, using their association with specific mRNAs as a mediator to identify and characterize cell types while preserving their in vivo state.
2Reliability
If mRNA purification is performed from fixed tissue, then gene expression can be analyzed in preserved samples, but technical challenges associated with reproducible purification occur
Solution Approach 1:
The patent extracts ribosome complexes from fixed tissue sections using affinity purification based on sequence-specific binding. This approach bypasses the difficult step of purifying mRNA from fixed tissue by instead purifying the ribosome-mRNA complexes directly, leveraging the stability of ribosomal proteins in fixed samples while maintaining access to the mRNA information.
Solution Approach 2:
The patent replaces the mechanical and chemical processes of mRNA purification with a sequence-specific affinity binding system. Instead of using complex purification protocols that struggle with fixed tissue, the method uses oligonucleotide probes that specifically bind to target mRNA sequences within ribosome complexes, enabling reproducible isolation from fixed samples.
3Quantity of substance
If whole-tissue microarrays are used for gene expression analysis, then comprehensive tissue profiling is achieved, but cell-type-enriched genes cannot be detected
Solution Approach 1:
The patent segments the heterogeneous tissue sample into cell-type-specific populations through affinity purification of ribosome complexes. By designing probes that bind to cell-type-specific mRNA sequences, the method isolates and analyzes the translational profile of specific cell types within the tissue, separating their gene expression signals from the whole-tissue background.
Solution Approach 2:
The patent applies local quality by targeting specific cell types within the heterogeneous tissue through sequence-specific affinity binding. The oligonucleotide probes are designed to recognize and bind only to mRNA sequences unique to particular cell types, enabling the detection of cell-type-enriched genes that would be masked in whole-tissue analysis.
4Measurement precision
If cell isolation is performed to obtain cell-type-specific transcripts, then individual cell type analysis is possible, but the process is technically challenging and not reproducible
Solution Approach 1:
The patent extracts cell-type-specific information by purifying ribosome complexes directly from tissue sections using affinity capture. This eliminates the need for complex cell isolation procedures by directly accessing the translational machinery in situ, simplifying the workflow while maintaining cell-type specificity through sequence-targeted purification.
Solution Approach 2:
The patent uses ribosome complexes as an intermediary to bridge tissue section analysis and cell-type-specific gene expression profiling. The ribosomes serve as stable, isolatable structures that retain their association with cell-type-specific mRNAs, providing a reproducible intermediate that can be purified and analyzed without requiring cell isolation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides a generalizable approach to elucidate biological properties of distinct cellular populations, identify molecular changes, and detect cell-type-enriched genes not detectable by whole-tissue microarrays, facilitating the identification of therapeutic targets for diseases and disorders.
Implementation Method 1
a nucleic acid construct that comprises the coding sequence for a tagged ribosomal protein under the control of a regulatory sequence so that the tagged ribosomal protein is selectively expressed in the particular cell type
Implementation Method 2
isolating, in vitro, ribosome complexes from cells of a non-human organism that contain a nucleic acid construct that comprises the coding sequence for a tagged ribosomal protein
Implementation Method 3
isolating the translated mRNA complexed with the protein, thereby identifying a profile of translated neuron mRNAs
Data Source
Figure 1
Figure 2a~2b
Figure 3a~3f
AI summary
Methods and compositions are provided for translational profiling and molecular phenotyping of specific tissues, cells and cell subtypes of interest. The methods provided herein facilitate the analysis of gene expression in the selected subset present within a heterogeneous sample.